Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial
by Bergmann, Lothar (Author)
, Albiges, L. (Author)
, Ahrens, M. (Author)
, Gross-Goupil, M. (Author)
, Boleti, E. (Author)
, Gravis, G. (Author)
, Fléchon, A. (Author)
, Grimm, M. -O. (Author)
, Bedke, J. (Author)
, Barthélémy, P. (Author)
, Castellano, D. (Author)
, Mellado, B. (Author)
, Ivanyi, P. (Author)
, Rottey, S. (Author)
, Flörcken, A. (Author)
, Suarez, C. (Author)
, Maroto, P. (Author)
, Grünwald, V. (Author)
, Oosting, S. F. (Author)
, Kopecky, J. (Author)
, Zschäbitz, Stefanie (Author)
, Boegemann, M. (Author)
, Buchler, T. (Author)
, Niegisch, G. (Author)
, Goebell, P. J. (Author)
, Waddell, T. (Author)
, Joly, F. (Author)
, Priou, F. (Author)
, Retz, M. (Author)
, Siemer, S. (Author)
, Zimmermann, U. (Author)
, Deckbar, D. (Author)
, Burkholder, I. (Author)
, Hartmann, A. (Author)
, Haanen, J. B. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource